Michael David Garrison - 26 Nov 2025 Form 4 Insider Report for BECTON DICKINSON & CO (BDX)

Role
EVP & Pres Med.Essntl&BioPharm
Signature
Donna Kalazdy, by power of attorney from Michael David Garrison
Issuer symbol
BDX
Transactions as of
26 Nov 2025
Net transactions value
$0
Form type
4
Filing time
01 Dec 2025, 12:09:42 UTC
Previous filing
22 Jul 2025
Next filing
17 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Garrison Michael David EVP & Pres Med.Essntl&BioPharm C/O BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES Donna Kalazdy, by power of attorney from Michael David Garrison 01 Dec 2025 0001944816

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDX Common Stock Award $0 +7,568 +155% $0.000000 12,455 26 Nov 2025 Direct F1
transaction BDX Common Stock Award $0 +3,048 +24% $0.000000 15,503 26 Nov 2025 Direct F2
transaction BDX Common Stock Tax liability $0 -1,769 -11% $0.000000 13,734 26 Nov 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
F2 Represents shares received upon vesting of performance-based equity awards.
F3 Represents shares withheld for payment of withholding taxes in connection with (A) the vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units previously reported on Table I.